Events

GENDERACTIONplus Final Conference Towards new Horizons: Inclusive Gender Equality in FP10 and Beyond
FEB
Wed
12
09:00 - 17:30

Starts in 1 week from now

Location

Brussels and online

Ateliers des Tanneurs
Huidevettersstraat 58-62
1000 Brussels
Programmes
Enhancing EU R&I

The aim of the GENDERACTIONplus conference Towards new Horizons: Inclusive Gender Equality in FP10 and Beyond is to review the progress made in advancing inclusive gender equality in research and innovation in the EU, assess advances in policy coordination accomplished through GENDERACTIONplus Communities of Practice, and engage in a 'whole system’ dialogue with policy makers, research funders, ERA stakeholder organisations, ERA gender equality officers, and scholars, to discuss the challenges and opportunities ahead.

More information on the conference including the programme and registration form is available in the announcement on the GENDERACTIONplus project webpage. The onsite registrations close on 31 January 2025.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.